Herantis Pharma Oyj Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 18, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	41	31	32	28	27	40	Upgrade
Market Cap Growth	-5.33%	-3.81%	13.79%	4.72%	-34.19%	-21.79%	Upgrade
Enterprise Value	36	27	31	25	26	39	Upgrade
Last Close Price	1.70	1.51	1.57	1.65	2.28	3.95	Upgrade
PE Ratio	-	-	113.47	-	-	-	Upgrade
Forward PE	-	-	-	-	-	1.42	Upgrade
PB Ratio	23.35	-125.74	6.72	-462.92	-23.37	5.34	Upgrade
P/TBV Ratio	23.35	-	6.72	-	-	5.34	Upgrade
EV/EBIT Ratio	-	-	203.31	-	-	-	Upgrade
Debt / Equity Ratio	0.01	-0.30	0.01	-75.33	-6.43	0.95	Upgrade
Quick Ratio	7.47	4.01	3.38	3.26	2.89	4.67	Upgrade
Current Ratio	8.10	4.06	3.39	3.28	2.91	4.68	Upgrade
Return on Equity (ROE)	-287.85%	-220.33%	12.00%	-	-396.06%	-193.95%	Upgrade
Return on Assets (ROA)	-74.56%	-67.44%	1.49%	-71.39%	-64.41%	-36.70%	Upgrade
Return on Capital (ROIC)	-169.92%	-136.82%	2.09%	-93.60%	-74.22%	-42.30%	Upgrade
Return on Capital Employed (ROCE)	-	-	3.20%	-	-	-	Upgrade
Earnings Yield	-13.35%	-16.17%	0.88%	-33.41%	-47.91%	-22.60%	Upgrade
FCF Yield	-	-21.43%	-14.60%	-32.05%	-37.28%	-21.14%	Upgrade
Buyback Yield / Dilution	-17.58%	-17.25%	-17.34%	-43.59%	-38.03%	-26.51%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.